Historique
Rapport
ATS and HIV risk and transmission. Part 2/5
Titre de série :
Systematic literature review on stimulant use and HIV
Auteur(s) :
ONUDC / UNODC (Office des Nations Unies contre la drogue et le crime / United Nations Office on Drugs and Crime)
Année
2017
Page(s) :
83 p.
Sous-type de document :
Revue de la littérature
Langue(s) :
Anglais
Éditeur(s) :
Vienna : UNODC
Domaine :
Drogues illicites
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
VIH
;
HEPATITE
;
FACTEUR DE RISQUE
;
INFECTION
;
HSH
;
AMPHETAMINE
;
INJECTION
;
PROSTITUTION
;
USAGER
;
CONDUITE A RISQUE
;
POPULATION A RISQUE
;
STIMULANTS
Note générale :
ATS = amphetamine-type stimulants
Résumé :
The objective of this review is to carry out a review of published and grey literature on the evidence of injecting and non-injecting stimulant use (particularly crack, cocaine and ATS) and their possible link to HIV, HCV & HBV vulnerability and transmission. To identify:
- The extent of HIV, HCV and HBC infection among stimulant users;
- Specific subgroups of stimulant users at greater risk of HIV, HCV and HBV infection;
- Temporal and geographical patterns of HIV, HCV and HBV infection among stimulant users.
The present review identified a substantial amount of evidence on the link between HIV risk and ATS use. This association has been most commonly researched in North America, Eastern Europe, East and South East Asia. Most of the studies included in the present review had a cross-sectional design and were conducted in developed countries, particularly in the United States. The majority of the evidence focused on men who have sex with men. There is a dearth of evidence on other vulnerable groups, such as prison-based populations and sex workers. Most of the studied samples had an average age of 30 years old and were generally made by two-thirds of male participants. Nevertheless, women, younger and older adults who use ATS might still be vulnerable to HIV and other sexually transmitted diseases and infections.
- The extent of HIV, HCV and HBC infection among stimulant users;
- Specific subgroups of stimulant users at greater risk of HIV, HCV and HBV infection;
- Temporal and geographical patterns of HIV, HCV and HBV infection among stimulant users.
The present review identified a substantial amount of evidence on the link between HIV risk and ATS use. This association has been most commonly researched in North America, Eastern Europe, East and South East Asia. Most of the studies included in the present review had a cross-sectional design and were conducted in developed countries, particularly in the United States. The majority of the evidence focused on men who have sex with men. There is a dearth of evidence on other vulnerable groups, such as prison-based populations and sex workers. Most of the studied samples had an average age of 30 years old and were generally made by two-thirds of male participants. Nevertheless, women, younger and older adults who use ATS might still be vulnerable to HIV and other sexually transmitted diseases and infections.